Cancer Kidney Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Kidney Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Kidney Cancer Projects
--Active Biotech
--Abbott Laboratories
--Alfacell Corp
--Agennix Incorporated
--Argos Therapeutics, Inc.,
--erly Merix Bioscience)
--Amgen Inc
--Bayer Ag
--AVEO Pharmaceuticals, Inc.
--erly GenPath Pharmaceuticals, Inc.)
--Centocor, Inc.
--Bristol-Myers Squibb Company
--Esteve
--Curacyte AG
--Genta Incorporated
--Genentech Inc
--Idera Pharmaceuticals Inc
--GlaxoSmithKline plc
--Oxford BioMedica plc
--Onyx Pharmaceuticals Inc
--ZymoGenetics Inc
--WILEX AG

--Top Companies in early stage Kidney Cancer Projects
--Amgen Inc
--Advantagene, Inc.
--Archemix Corp.
--Antisoma PLC
--CuraGen Corp
--Avantogen Limited
--erly Australian Cancer Technology Limited)
--Gene Signal International SA
--EntreMed Inc
--Onyvax Limited
--Innate Pharma S.A.
--Protox Therapeutics Inc.
--PharmaMar
--Seattle Genetics Inc
--Raven biotechnologies, inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View